Willingdon Wealth Management’s Quest Diagnostics DGX Stock Holding History

Willingdon Wealth Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$1.5M	Sell	18,648 -1,339	-7%	-$139K	0.38%	66
2019 Q4	$2.13M	Sell	19,987 -250	-1%	-$26.1K	0.44%	71
2019 Q3	$2.17M	Sell	20,237 -73	-0.4%	-$7.49K	0.48%	72
2019 Q2	$2.07M	Sell	20,310 -248	-1%	-$23.8K	0.48%	72
2019 Q1	$1.85M	Buy	20,558 +571	+3%	+$49.5K	0.45%	74
2018 Q4	$1.66M	Buy	19,987 +19,929	+34,360%	+$1.87M	0.48%	82
2018 Q3	$6K	Hold	58	–	–	﹤0.01%	320
2018 Q2	$6K	Hold	58	–	–	﹤0.01%	283
2018 Q1	$6K	Hold	58	–	–	﹤0.01%	296
2017 Q4	$6K	Hold	58	–	–	﹤0.01%	274
2017 Q3	$5K	Buy	+58	New	+$6.16K	﹤0.01%	256

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Willingdon Wealth Management's DGX Position: Q1 2020 in Review

Willingdon Wealth Management reduced its Quest Diagnostics (DGX) stake by 6.7% in Q1 2020, selling an estimated $139K and leaving 18,648 shares worth $1.5M. The position accounts for 0.38% of the portfolio, ranked #66.

Willingdon Wealth Management first reported a position in DGX in Q3 2017 and has held it in 11 quarters since. The position peaked at $2.17M in Q3 2019. 714 funds tracked by Wall St. Rank hold DGX as of Q1 2020.

Willingdon Wealth Management held 18,648 shares of Quest Diagnostics worth $1.5M as of Q1 2020.
Willingdon Wealth Management sold 1,339 Quest Diagnostics shares in Q1 2020, an estimated $139K.
Quest Diagnostics made up 0.38% of Willingdon Wealth Management's portfolio in Q1 2020, its #66 holding.
Willingdon Wealth Management first reported a position in Quest Diagnostics in Q3 2017 and has held it in 11 quarters since.
Willingdon Wealth Management's Quest Diagnostics position peaked at $2.17M in Q3 2019.
714 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2020.

Based on Willingdon Wealth Management's 13F filing for Q1 2020, filed 21 Apr 2020.